{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:33:28Z","timestamp":1762900408261,"version":"3.44.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770116"],"award-info":[{"award-number":["81770116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20180307150419435","JCYJ20190809180213349","JCYJ20210324123004011"],"award-info":[{"award-number":["JCYJ20180307150419435","JCYJ20190809180213349","JCYJ20210324123004011"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM202011004"],"award-info":[{"award-number":["SZSM202011004"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.thromres.2023.01.029","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T04:23:51Z","timestamp":1675311831000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The heat shock protein DNAJB2 as a novel biomarker for essential thrombocythemia diagnosis associated with immune infiltration"],"prefix":"10.1016","volume":"223","author":[{"given":"Hui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Man","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.thromres.2023.01.029_bb0005","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1816082","article-title":"Essential thrombocythemia","volume":"381","author":"Tefferi","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.thromres.2023.01.029_bb0010","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2023.01.029_bb0015","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/leu.2016.291","article-title":"Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria","volume":"31","author":"Gisslinger","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.thromres.2023.01.029_bb0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.14061","article-title":"Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic\/myeloproliferative neoplasms in the United States, 2001\u201312","volume":"174","author":"Srour","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2023.01.029_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ejh.12256","article-title":"Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union","volume":"92","author":"Moulard","year":"2014","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2023.01.029_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.leukres.2011.06.024","article-title":"MPL immunohistochemical expression as a novel marker for essential thrombocythemia and primary myelofibrosis differential diagnosis","volume":"36","author":"Ponce","year":"2012","journal-title":"Leuk. Res."},{"issue":"9","key":"10.1016\/j.thromres.2023.01.029_bb0035","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1182\/blood.2020008043","article-title":"Clinical insights into the origins of thrombosis in myeloproliferative neoplasms","volume":"137","author":"Moliterno","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.01.029_bb0040","doi-asserted-by":"crossref","first-page":"637116","DOI":"10.3389\/fonc.2021.637116","article-title":"Triple-negative essential thrombocythemia: clinical-pathological and molecular features. A single-center Cohort Study","volume":"11","author":"Cattaneo","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2023.01.029_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/ejh.12687","article-title":"Interferon-\u03b1 induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera","volume":"97","author":"Riley","year":"2016","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2023.01.029_bb0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1160\/TH13-11-0949","article-title":"B cells facilitate platelet production mediated by cytokines in patients with essential thrombocythaemia","volume":"112","author":"Liu","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2023.01.029_bb0055","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2005.05674.x","article-title":"Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases","volume":"130","author":"Panteli","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.thromres.2023.01.029_bb0060","first-page":"657","article-title":"Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia","volume":"89","author":"Marta","year":"2004","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.thromres.2023.01.029_bb0065","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2023.01.029_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajh.26050","article-title":"Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management","volume":"96","author":"Tefferi","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"24","key":"10.1016\/j.thromres.2023.01.029_bb0075","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00018-006-6272-7","article-title":"Oncogenic mechanisms in myeloproliferative disorders","volume":"63","author":"Delhommeau","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.thromres.2023.01.029_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.seminhematol.2018.04.005","article-title":"Somatic mutations in Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"55","author":"Ferreira Cristina","year":"2018","journal-title":"Semin. Hematol."},{"issue":"12","key":"10.1016\/j.thromres.2023.01.029_bb0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41408-018-0157-5","article-title":"Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates","volume":"8","author":"Szuber","year":"2018","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.thromres.2023.01.029_bb0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bjh.13605","article-title":"How we diagnose and treat essential thrombocythaemia","volume":"171","author":"Alimam","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2023.01.029_bb0095","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/leu.2008.357","article-title":"Molecular profile of CD34+ stem\/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia","volume":"23","author":"Catani","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2023.01.029_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.exphem.2019.10.001","article-title":"Shared and tissue-specific expression signatures between bone marrow from primary myelofibrosis and essential thrombocythemia","volume":"79","author":"Ishikawa","year":"2019","journal-title":"Exp. Hematol."},{"issue":"10","key":"10.1016\/j.thromres.2023.01.029_bb0105","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2003-07-2597","article-title":"Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells","volume":"104","author":"Tenedini","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2023.01.029_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1160\/TH05-01-0037","article-title":"Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype","volume":"94","author":"Gnatenko","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2023.01.029_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J."},{"issue":"16","key":"10.1016\/j.thromres.2023.01.029_bb0120","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","article-title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","volume":"131","author":"Xu","year":"2018","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.thromres.2023.01.029_bb0125","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1182\/blood.2019003976","article-title":"Lessons to learn from tumor-educated platelets","volume":"137","author":"Roweth","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2023.01.029_bb0130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell"},{"issue":"26","key":"10.1016\/j.thromres.2023.01.029_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201907692","article-title":"Engineered PD-L1-expressing platelets reverse new-onset type 1 diabetes","volume":"32","author":"Zhang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.thromres.2023.01.029_bb0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3389\/fimmu.2020.00747","article-title":"Platelets in neurodegenerative conditions-friend or foe?","volume":"11","author":"Leiter","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2023.01.029_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101695","article-title":"Platelets: the missing link between the blood and brain?","volume":"183","author":"Leiter","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"8","key":"10.1016\/j.thromres.2023.01.029_bb0150","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.2022015970","article-title":"The multifaceted role of platelets in mediating brain function","volume":"140","author":"Burnouf","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.01.029_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/986254","article-title":"Assessment of platelet indices in patients with neurodegenerative diseases: mean platelet volume was increased in patients with Parkinson's disease","volume":"2013","author":"Ko\u00e7er","year":"2013","journal-title":"Curr. Gerontol. Geriatr. Res."},{"issue":"3","key":"10.1016\/j.thromres.2023.01.029_bb0160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp-2018-318854","article-title":"Platelet abnormalities in Huntington's disease","volume":"90","author":"Denis","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.thromres.2023.01.029_bb0165","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2018.00406","article-title":"Fresh evidence for platelets as neuronal and innate immune cells: their role in the activation, differentiation, and deactivation of Th1, Th17, and tregs during tissue inflammation","volume":"9","author":"Ponomarev","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2023.01.029_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejpn.2012.08.005","article-title":"Regulated granule trafficking in platelets and neurons: a common molecular machinery","volume":"17","author":"Goubau","year":"2013","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"11","key":"10.1016\/j.thromres.2023.01.029_bb0175","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/stem.1777","article-title":"Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1\/2 and F-actin reorganization","volume":"32","author":"Ye","year":"2014","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.thromres.2023.01.029_bb0180","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1634\/stemcells.2007-0048","article-title":"Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem\/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis","volume":"25","author":"Yang","year":"2007","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.thromres.2023.01.029_bb0185","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410370604","article-title":"Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson's disease","volume":"37","author":"Haas","year":"1995","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.thromres.2023.01.029_bb0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00702-003-0103-x","article-title":"Platelet monoamine oxidase activity in subjects tested for Huntington's disease gene mutation","volume":"111","author":"Markianos","year":"2004","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"8","key":"10.1016\/j.thromres.2023.01.029_bb0195","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.thromres.2023.01.029_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031102","article-title":"Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.thromres.2023.01.029_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25215079","article-title":"Role of inositols and inositol phosphates in energy metabolism","volume":"25","author":"Chatree","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.thromres.2023.01.029_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100711","article-title":"Role of inflammation in the biology of myeloproliferative neoplasms","volume":"42","author":"Koschmieder","year":"2020","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.thromres.2023.01.029_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"23","key":"10.1016\/j.thromres.2023.01.029_bb0220","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1182\/bloodadvances.2021004438","article-title":"Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced disease","volume":"5","author":"M\u00fcller","year":"2021","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.thromres.2023.01.029_bb0225","first-page":"1022","article-title":"JAK2V617F mutation and TNF-\u03b1 expression in myeloproliferative neoplasms and their correlation","volume":"22","author":"Sun","year":"2014","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"9","key":"10.1016\/j.thromres.2023.01.029_bb0230","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1007\/s12035-022-02920-5","article-title":"Genetic analysis of HSP40\/DNAJ family genes in Parkinson's disease: a large case-control study","volume":"59","author":"Zhang","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.thromres.2023.01.029_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041409","article-title":"Neuromuscular diseases due to chaperone mutations: a review and some new results","volume":"21","author":"Sarparanta","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.thromres.2023.01.029_bb0240","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2353\/ajpath.2010.090663","article-title":"DNAJB2 expression in normal and diseased human and mouse skeletal muscle","volume":"176","author":"Claeys","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.thromres.2023.01.029_bb0245","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5847\/wjem.j.1920-8642.2022.021","article-title":"The expression of oxidative stress genes related to myocardial ischemia reperfusion injury in patients with ST-elevation myocardial infarction","volume":"13","author":"Gu","year":"2022","journal-title":"World J Emerg Med"},{"issue":"2","key":"10.1016\/j.thromres.2023.01.029_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100995","article-title":"Extracellular heat shock proteins and cancer: new perspectives","volume":"14","author":"Albakova","year":"2021","journal-title":"Transl. Oncol."},{"issue":"11","key":"10.1016\/j.thromres.2023.01.029_bb0255","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cub.2005.04.058","article-title":"HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome","volume":"15","author":"Westhoff","year":"2005","journal-title":"Curr. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2023.01.029_bb0260","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/sj.mt.6300163","article-title":"Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease","volume":"15","author":"Howarth","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.thromres.2023.01.029_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2020.126609","article-title":"Screening of hub genes and prediction of putative drugs in arsenic-related bladder carcinoma: an in silico study","volume":"62","author":"Zhang","year":"2020","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"11","key":"10.1016\/j.thromres.2023.01.029_bb0270","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/jcb.30326","article-title":"The role of heat shock proteins in metastatic colorectal cancer: a review","volume":"123","author":"Javid","year":"2022","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.thromres.2023.01.029_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010049","article-title":"Altered Ca(2+) homeostasis in red blood cells of polycythemia Vera patients following disturbed organelle sorting during terminal erythropoiesis","volume":"11","author":"Buks","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.thromres.2023.01.029_bb0280","first-page":"611","article-title":"Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain","volume":"26","author":"Ottaviani","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.thromres.2023.01.029_bb0285","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12032-022-01825-6","article-title":"Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype","volume":"39","author":"Bassan","year":"2022","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.thromres.2023.01.029_bb0290","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.thromres.2023.01.029_bb0295","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00277-018-3332-7","article-title":"Distinctive CD8(+) T cell and MHC class I signatures in polycythemia vera patients","volume":"97","author":"Cardoso","year":"2018","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2023.01.029_bb0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.leukres.2019.02.010","article-title":"Programmed cell death receptor (PD-1) ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"79","author":"Wang","year":"2019","journal-title":"Leuk. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:50:41Z","timestamp":1758736241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482300035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":60,"alternative-id":["S004938482300035X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.01.029","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The heat shock protein DNAJB2 as a novel biomarker for essential thrombocythemia diagnosis associated with immune infiltration","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}